Kantify

Kantify

Foundation date

17/04/2015

Sector

#Biotechnology / R&D Services

Subsector

• #R&D Services - Analytical services
• #R&D Services - Bioinformatics
• #R&D Services - CRO (Contract Research Organization)
• #R&D Services - Diagnostic services
• #R&D Services - Drug delivery
• #R&D Services - Proteomics
• #R&D Services - Screening
• #Other - AgBio
• #Pharma - Nucleic acid drugs
• #Pharma - Small molecule therapeutics
• #Medtech - Ophthalmic and optical devices
• #Professional Services - Business development
• #Professional Services - Communication & PR/IR
• #Professional Services - Deal arranger
• #Professional Services - Drug development consulting
• #Professional Services - Due diligence
• #Professional Services - Information provider
• #Professional Services - IT services
• #Professional Services - Legal services
• #Professional Services - Management consulting
• #Professional Services - Market access
• #Professional Services - Market research
• #Professional Services - Operations/Health & safety/Purchasing
• #Professional Services - Sales & Marketing
• #Professional Services - Technology transfer
• #Supplier - Software/eHealth

Therapeutic areas

• #Conditions originating in the perinatal period

Short description

Kantify is a startup based in Brussels with the mission to improve human health through Artificial Intelligence. Its core business is to build AI software solutions using state-of-the-art techniques accompanied by many in-house innovations, curated datasets, novel featurization techniques, and optimized infrastructure.

Expertise

AI-powered drug discovery:

Kantify has developed a unique end-to-end in silico drug discovery solution :

• to help identify the macromolecule target that is causing the diseases

• to find novel hits from diverse chemical scaffolds (in silico)

• to predict promising lead compounds making sure they are both to be effective and not have adverse effects (ex: heart toxicity, liver toxicity, drug-drug interaction, etc.)

• to reduce clinical trial failure rate by leveraging patient genomic data.

AI-powered clinical diagnostics and laboratory automation

• to help diagnose endometrial diseases and uterus cancer from tissue images

• to detect and predict heart failure and arrhythmia from signal data

• to detect and segment beast cancer using whole-slide images, to perform complete blood-cell count and analysis from blood smear images (including Acute Leukemia detection)

• to automate spermatozoa motility analysis.